Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity.
about
Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptorIdentification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptorTranscriptional regulation of PIK3CA oncogene by NF-kappaB in ovarian cancer microenvironment.Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cellsGeneration of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor.Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor.Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor.The tumor necrosis factor receptor and human neutrophil function. Deactivation and cross-deactivation of tumor necrosis factor-induced neutrophil responses by receptor down-regulation.Tumor necrosis factor induces phosphorylation of a 28-kDa mRNA cap-binding protein in human cervical carcinoma cells.Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line.Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor.TNF ligands and receptors--a matter of life and death.Covalent cross-linking of the Phytophthora megasperma oligopeptide elicitor to its receptor in parsley membranes.Tumor necrosis factor inhibits MYC expression in HL-60 cells at the level of mRNA transcription.A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity.A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae.Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor.Tumor necrosis factor expression in human epithelial tumor cell linesTumor necrosis factor-alpha inhibits expression of pulmonary surfactant proteinRecombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayersTumour necrosis factor in man: clinical and biological observations.Activation of mouse peritoneal macrophages by monoclonal antibodies to Mac-1 (complement receptor type 3)Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factorTumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteinsMonoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells.Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cellsThe amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cellsAdenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis.Identification of a putative receptor for subgroup A feline leukemia virus on feline T cells.The expression of tumor necrosis factor-alpha, its receptors and steroidogenic acute regulatory protein during corpus luteum regression.The two different receptors for tumor necrosis factor mediate distinct cellular responses.Structural changes of tumor necrosis factor alpha associated with membrane insertion and channel formation.Interleukins and tumor necrosis factor in inflammation.Tumour necrosis factor: a cytokine with multiple biological activities.
P2860
Q24304040-FE87ED03-3C94-4E20-8422-5815B8AD2BB9Q24315622-11C4FFA5-CACB-4CF2-BFD0-B473A5BE266AQ33323364-304676F5-F4EE-47C0-BF61-789461443A55Q33336314-EF35E287-1C90-4E75-94E5-7A12F670067DQ33632011-93B675D9-FFDB-41CB-A5BD-E273248D6582Q33648545-9C9F1EB4-1C8C-40E9-9DC5-4D90F5270802Q33673534-C5CB1A0E-CE18-4B3C-9682-FDCF9C5EBC5FQ33739657-55ED9F82-A9FB-4AD2-BCE3-8AC0A522718EQ33937497-19CF4FC6-2CBE-4AAB-A9E9-E15BF19E6C48Q34255987-8172A8CC-7D93-4A3B-896B-8BAEE9788CF4Q34316477-0C5073A8-8F37-43B7-80E9-0E1B10116B50Q34347198-DED1ABCB-9FFF-4E5C-9ADF-F9F529888A67Q34375941-E256BF0D-BACB-4A07-8A6E-0215A1E02A38Q34542205-CE6F3BCF-D34A-4CA2-B28F-CB3671DA0F1FQ34587654-2A5CD48E-0737-4F80-A7C3-92632E49AE86Q34589176-940A3EDA-0E54-48C9-BA69-B08C6C107A93Q34623575-37DC167C-53E8-4C3B-8EB5-BD82661F199FQ34661010-4DFB3E2D-8787-4775-9BF6-BB02E7D17CDBQ35590901-E65AB766-7245-41B0-A93B-AB20BD369791Q35612515-F5E7B502-0433-4E4F-ACFF-7D0C26DCFB99Q35617405-2050CD3C-A9B8-4D18-911E-9A9A1290B85FQ35739690-8548E4C6-ECDD-4DA0-980C-D9CDC0A2D539Q35809637-94AFD46A-CA44-438F-BEA3-7399EBE5DD15Q35817606-6247C07A-7AEB-48B0-BABB-5C62D51E99F1Q35835763-53FF3A0A-051E-4A86-837A-5889FA7F1FEBQ36029538-C4920239-FD3C-48E0-8647-B664A2FCDC3FQ36352448-11B0CF31-17BE-4043-9A9D-39F99FF23E63Q36352972-5BC3BEE1-34E8-4813-B24C-9DB87A657D0EQ36356510-5840599E-FCF4-4C08-8FB7-C5F9BAFF0AACQ36364423-BB40256C-CC6C-4B25-AE7A-0F8901F96D6DQ36433185-2E1C94EE-1246-4283-B00D-ECA80F0261C4Q36664480-0A6DA6F3-3807-4726-AAAD-C5F7962C8C92Q36681830-D21D6E5E-5FDF-431C-AB05-207050B0A844Q36689099-3567144F-F55F-4376-BFE8-0CAFC5F74A75Q36698194-0F580E2A-35C8-4B5C-A68E-76DF78ED4445Q36976527-EE63195C-2F4C-46AF-A53E-3997E24474C5Q37609601-FCB2EB3F-F4CC-4443-8BD9-749B9C6B03C2Q37728008-08787EF9-1943-4364-8701-4D5689A97C82Q37826486-1FF73C79-7908-40F7-9DF7-1F8C53BDFE15Q37916679-E5C47885-B5AD-4609-B657-50D44A4D8479
P2860
Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cellular receptor for 125I-lab ...... d relationship to sensitivity.
@en
Cellular receptor for 125I-lab ...... d relationship to sensitivity.
@nl
type
label
Cellular receptor for 125I-lab ...... d relationship to sensitivity.
@en
Cellular receptor for 125I-lab ...... d relationship to sensitivity.
@nl
prefLabel
Cellular receptor for 125I-lab ...... d relationship to sensitivity.
@en
Cellular receptor for 125I-lab ...... d relationship to sensitivity.
@nl
P2093
P2860
P356
P1476
Cellular receptor for 125I-lab ...... d relationship to sensitivity.
@en
P2093
Cuatrecasas P
Kull FC Jr
P2860
P304
P356
10.1073/PNAS.82.17.5756
P407
P577
1985-09-01T00:00:00Z